Annals of Neurology

Article	Citations
	215
Reply to “Urinary α‐Synuclein for Parkinson's Detection: Key Limitations and Future Directions”	184
Issue Information	159
	133
Vertebral Artery Pseudoaneurysm: Novel Marker of Bow Hunter's Syndrome	121
HLA Associations of Intrathecal IgG Production against Specific Viruses in Multiple Sclerosis	119
	103
Annals of Neurology: Volume 97, Number 1, January 2025	99
Septin‐5 and ‐7‐IgGs: Neurologic, Serologic, and Pathophysiologic Characteristics	97
Cortical Microhemorrhage Presentation of Small Vessel Primary Angiitis of the Central Nervous System	97
Network Localization of Awareness in Visual and Motor Anosognosia	90
Blood Pressure after Successful Endovascular Therapy: A Systematic Review and Meta‐Analysis of Randomized Control Trials	87
Carotid Stent Fracture	82
Microneurography Reveals Unmyelinated Small Nerve Fiber Dysfunction in Long COVID	82
Staufen Impairs Autophagy in Neurodegeneration	81
Effect of Imaging Markers on Reperfusion Therapy in Basilar Artery Occlusion	79
Furthering Female Faculty: An American Neurological Association/Association of University Professors of Neurology Perspective	78
Interactions between High Seroreactivity to Human Herpes Virus 6A and Epstein–Barr Virus in MS Development: A Presymptomatic Case–Control Study	78
A Letter Concerning a Role for Blood–Brain Barrier Dysfunction in Delirium following Noncardiac Surgery in Older Adults	78
Supratentorial Lymphocytic Inflammation with Parenchymal Perivascular Enhancement Responsive to Steroids: A Potentially Overlooked Diagnosis	77
The Use of Antihypertensive Medication and In Vivo Alzheimer's Disease Pathology	74
Guanylate Kinase 1 Deficiency: A Novel and Potentially Treatable Mitochondrial DNA Depletion/Deletions Disease	74
Association of Retromer Deficiency and Tau Pathology in Down Syndrome	71
Probabilistic Mapping Reveals Optimal Stimulation Site in Essential Tremor	70
Dysregulation of Gut Microbiota‐Derived Neuromodulatory Amino Acid Metabolism in Human Immunodeficiency Virus‐Associated Neurocognitive Disorder: An Integrative Metagenomic and Metabolomic	64

Epidemiology, Survival, and Clinical Characteristics of Inclusion Body Myositis	61
MS ‐Driven Metabolic Alterations Are Recapitulated in iPSC ‐Derived Astrocytes	60
Cerebrospinal Fluid Flow in Patients with Huntington's Disease	59
Frailty across Neurological Diseases: Why Sex and Gender Matter	59
Efficacy and Safety of Ofatumumab Treatment for Anti‐NMDA Receptor Autoimmune Encephalitis (OFF‐AE): A Prospective, Multicenter Cohort Study	57
Before, during, and after: An Argument for Safety and Improved Outcome of Thrombolysis in Acute Ischemic Stroke with Direct Oral Anticoagulant Treatment	56
Plasma Metabolites Link Dietary Patterns to Stroke Risk	56
Elevated Cerebrospinal Fluid Ubiquitin Carboxyl‐Terminal Hydrolase Isozyme L1 in Asymptomatic C9orf72 Hexanucleotide Repeat Expansion Carriers	56
Diet, Pace of Biological Aging, and Risk of Dementia in the Framingham Heart Study	55
Prevalence of Cerebral Amyloid Angiopathy and Associated Risk of Subsequent Ischemic and Hemorrhagic Stroke and Mortality in a Nationwide Cohort	55
Biological Age Acceleration and Motoric Cognitive Risk Syndrome	55
A Managed Care System with Telemedicine Support for Neurological Emergencies	54
Management of Cerebral Venous Thrombosis Due to Adenoviral COVID‐19 Vaccination	52
A Role for Insulin‐like Growth Factor 1 in the Generation of Epileptic Spasms in a murine model	50
Severity of GNAO1‐Related Disorder Correlates with Changes in G‐Protein Function	48
Cover Image	48
Suvorexant Acutely Decreases Tau Phosphorylation and Aβ in the Human CNS	48
Cross‐Sectional FDG in Down Syndrome and Autosomal Dominant Alzheimer's Disease	47
Issue Information	47
Annals of Neurology: Volume 94, Number S30, September 2023	47
Longitudinal Imaging Biomarkers Correlate with Progressive Motor Deficit in the Mouse Model of Charlevoix‐Saguenay Ataxia	46
MEK Pathway Inhibitor‐Mediated Response in BRAF V600‐Mutant Melanoma with Brain Parenchymal and Leptomeningeal Metastases	45
Sports Concussion and Category Mistakes	45
Clarifying the Moderating Role of Socioeconomic Status on Amyloid‐Related Gray Matter Atrophy	44
Issue Information	44
Correction: Regional Glymphatic Abnormality in Behavioral Variant Frontotemporal Dementia	44
Tenascin‐R Autoimmunity: Isolated Tremor Reversed with Immunotherapy	43
Ultrastructural Axon–Myelin Unit Alterations in Multiple Sclerosis Correlate with Inflammation	43
Trials for Slowly Progressive Neurogenetic Diseases Need Surrogate Endpoints	43
GGC Repeat Expansion of RILPL1 is Associated with Oculopharyngodistal Myopathy	43
APOE2 Exacerbates TDP‐43 Related Toxicity in the Absence of Alzheimer Pathology	43
Correction: GATA1‐Mediated Transcriptional Regulation of the γ‐Secretase Activating Protein Increases Aβ Formation in Down Syndrome	43
Micro‐Doses of DNP Preserve Motor and Muscle Function with a Period of Functional Recovery in Amyotrophic Lateral Sclerosis Mice	43
Sensorimotor Cortex High Frequency Oscillations Characterize Motor Symptom Severity during Deep Brain Stimulation Surgery for Parkinson's Disease	43
Development of Parkinson Disease and Its Relationship with Incidentally Discovered White Matter Disease and Covert Brain Infarction in a Real‐World Cohort	42
RAN Translation of C9orf72‐Related Dipeptide Repeat Proteins in Zebrafish Recapitulates Hallmarks of Amyotrophic Lateral Sclerosis and Identifies Hypothermia as a Therap	41
Dopamine Transporter Imaging as Objective Monitoring Biomarker in Parkinson's Disease	40
GABRA1‐Related Disorders: From Genetic to Functional Pathways	40
A Combined Panel of Salivary Biomarkers in de novo Parkinson's Disease	40
Intravenous Thrombolysis in Patients Taking Direct Oral Anticoagulation Treatment Before Stroke Onset: Results from the Safe Implementations of Treatments in Stroke International Stroke Registry	40
Association of Seizure Control with Mortality, Cognition, and Function in People With Dementia	40
Improving Early Recognition of Treatment‐Responsive Causes of Rapidly Progressive Dementia: The STAM3P Score	39
Visual Features in Stereo‐Electroencephalography to Predict Surgical Outcome: A Multicenter Study	39
Regional Brain Metabolism across the Alzheimer's Disease Continuum in Down Syndrome	39
Choroid Plexus Enlargement Exacerbates White Matter Hyperintensity Growth through Glymphatic Impairment	39
Illusions of Self‐Motion during Magnetic Resonance‐Guided Focused Ultrasound Thalamotomy for Tremor	38
	37
Issue Information	37
Reply to “Letter on Multiple Acyl‐Coenzyme A Dehydrogenase Deficiency Is Associated with Sertraline Use”	37
NINDS Corner: The Helping to End Addiction Long‐Term Initiative and Pain Neurology	37

Is there an Association between Tuber Involvement of the Fusiform Face Area in Autism Diagnosis?	36
Reply to “Is There an Association between Tuber Involvement of the Fusiform Face Area in Autism Diagnosis?”	36
Bilateral Hearing Loss Caused by Inferior Collicular Infarction	36
Reply to “Chance Bias Arising from TSC2 Mutation Imbalance in the PREVeNT Trial”	35
Issue Information	34
Issue Information	34
Reply to “Clinical Relevance of Genetic Variants in Juvenile Stroke Patients: A Plea for a Precise Classification”	34
Autoimmune Glial Fibrillary Acidic Protein Astrocytopathy Is Associated with HLA‐A*3303 and HLA‐DPB1*0501	33
COVID‐19‐Associated Critical Illness Myopathy with Direct Viral Effects	33
High‐Dose Pulse Glucocorticoid Treatment Prevents White Matter Spinal Cord Pseudoatrophy in Newly Diagnosed Multiple Sclerosis	33
	33
Brain Iron Dysregulation in Iron Deficiency Anemia‐Related Restless Leg Syndrome Revealed by Neuron‐Derived Extracellular Vesicles: A Case–Control Study	33
Trigeminal Trophic Syndrome from Lateral Medullary Stroke	33
Uncovering Image‐Driven Subtypes with Distinct Pathology and Clinical Course in Autopsy‐Confirmed Four Repeat Tauopathies	33
Compensated Hypogonadism Identified in Males with Cluster Headache: A Prospective Case‐Controlled Study	33
Determinants of Infarct Core Growth During Inter‐hospital Transfer for Thrombectomy	33
Comment on Clinical, Prognostic, and Longitudinal Functional and Neuropsychological Features of West Nile Virus Neuroinvasive Disease in the United States: A Systematic Review and Meta‐Analysis	33
Recessive Variants in PIGG Cause a Motor Neuropathy with Variable Conduction Block, Childhood Tremor, and Febrile Seizures: Expanding the Phenotype	33
Heart Rate Profiles During Exercise and Incident Parkinson's Disease	32
Bleeding Risk of Dual Antiplatelet Therapy after Minor Stroke or Transient Ischemic Attack	32
Fighting Amyotrophic Lateral Sclerosis by Protecting the Liver? A Prospective Cohort Study	32
Nocturnal Pulse Event Frequency Is Reduced in Multiple System Atrophy	32
Responsiveness of the Scale for the Assessment and Rating of Ataxia and Natural History in 884 Recessive and Early Onset Ataxia Patients	32
Use of FDG ‐ PET in Balamuthia mandrillaris	32
Stage‐Dependent Biomarker Changes in Spinocerebellar Ataxia Type 3	32
Prophylactic Fetal Creatine Supplementation Improves Post‐Asphyxial EEG Recovery and Reduces Seizures in Fetal Sheep: Implications for Hypoxic–Ischemic Encephalopathy	32
Automated Neuroprognostication Via Machine Learning in Neonates with Hypoxic‐Ischemic Encephalopathy	31
Neocortical LBD in Women and Episodic Memory Decline in Men: Clarifying Sex Effects	31
Genome‐Wide Analysis of Structural Variants in Parkinson Disease	31
In Memoriam: Arthur Knight Asbury, MD (1928–2022)	31
Signs of Cortical Inflammation in Migraine Measured with Quantitative Magnetic Resonance Imaging: A Registry for Migraine (REFORM) Study	31
Greater Diffusion Restriction in White Matter in Preclinical Alzheimer Disease	31
Histopathological Correlates of Lobar Microbleeds in False‐Positive Cerebral Amyloid Angiopathy Cases	31
Actigraphy Enables Home Screening of Rapid Eye Movement Behavior Disorder in Parkinson's Disease	31
Extending the Interpretation of Biomarker Dynamics in SOD1 ‐ ALS Proteomics	31
Neuroimaging Biomarkers for Friedreich Ataxia: A Cross‐Sectional Analysis of the TRACK‐FA Study	31
Correction: Decreased Cerebrospinal Fluid Amyloid β 38, 40, 42, and 43 Levels in Sporadic and Hereditary Cerebral Amyloid Angiopathy	31
Issue Information – TOC	30
ANA Investigates: Atrial Fibrillation after Stroke	30
Issue Information	30
	30
Issue Information	30
Search Strategies for Alzheimer Protector Genes	29
Reply to “VAERS Could Miss or Misinterpret Neurological Side Effects of COVID Vaccinations”	29
ANA Podcasts & Webinars: Genetics of Epilepsy	29
Disease‐Modifying Drugs Extend Survival in Hereditary Transthyretin Amyloid Polyneuropathy	29
Pivotal Role of Slitrk1 in Adult Striatal Cholinergic Neurons in Mice: Implication in Tourette Syndrome	29
SRPK3 Is Essential for Cognitive and Ocular Development in Humans and Zebrafish, Explaining X‐Linked Intellectual Disability	28
Happy 75th National Institute of Neurological Disorders and Stroke	28
Correction to “Protective Effects of Socioeconomic Status and Lifestyle on Amyloid‐ and White Matter Hyperintensity‐Related Longitudinal Brain Atrophy and Cognitive Decline”	28
Reply to “The Role of EEG in Predicting Post‐Stroke Seizures and an Updated Prognostic Model (SeLECT‐EEG)”	28
Application of the Amyloid/Tau/Neurodegeneration Framework in Cognitively Intact Adults: The CABLE Study	28
Elevated Risk of Cerebral Arteriovenous Malformation Rupture during Pregnancy and Puerperium	28
Cerebral Small Vessel Disease Progression Increases Risk of Incident Parkinsonism	27
CADASIL Affects Multiple Aspects of Cerebral Small Vessel Function on 7T‐MRI	27
Spoken Language Alterations can Predict Phenoconversion in Isolated Rapid Eye Movement Sleep Behavior Disorder: A Multicenter Study	27
Adolescent Headache Due to Congenital Pelvic/Sacral Vascular Malformation	27
Extra Movements in Healthy People: Challenging the Definition and Diagnostic Practice of Tic Disorders	27
Evaluation of Soluble Colony Stimulating Factor 1 Receptor (CSF1R) in Peripheral Blood as a Diagnostic Marker of CSF1R‐Related Disorder (CSF1R‐RD) in a Muri	27
Cortical Correlates of Gait Compensation Strategies in Parkinson Disease	27
Comparative Safety of Antiseizure Medication Monotherapy for Major Malformations	27
Risk of Multiple Sclerosis in People Living with HIV: An International Cohort Study	26
Epstein–Barr Virus, Lower Vitamin D, Low Sun Exposure, and HLA‐DRB1*1501 Risk Variant Share Common Epigenetic Pathways Leading to Multiple Sclerosis Onset	26
Smouldering‐Associated Worsening in Multiple Sclerosis: An International Consensus Statement on Definition, Biology, Clinical Implications, and Future Directions	26
Subcortical Volumes as Early Predictors of Fatigue in Multiple Sclerosis	26
Effect of Cumulative Exposure to Ocrelizumab on Memory B‐Cell Repopulation Dynamics in Multiple Sclerosis	26
Ultra‐Low Level Somatic Mutations and Structural Variations in Focal Cortical Dysplasia Type II	25
Issue Information	25
Annals of Neurology: Volume 95, Number 4, April 2024	25
Issue Information	25
Issue Information	25
Correction to Lyden P, Pryor KE, Coffey CS, et al. Final results of the RHAPSODY trial: a multi‐center, phase 2 trial using a continual reassessment method to determine the safety and toler	25
Annual Report from the Editor‐in‐Chief (2024)	25
Annals of Neurology: Volume 96, Number 2, August 2024	25
Charcot Joint	24
Vessel Wall Imaging of a Carotid Web	24
Cinematic Rendering of Extracranial to Intracranial Arterial Bypass	24
Intravenous Thrombolysis with Tenecteplase for the Treatment of Acute Ischemic Stroke	24
Risk‐Based EEG Allocation: The Next Step for SeLECT‐EEG	24
Brainstem Ischemic Syndrome in NF2‐Related Schwannomatosis	24

Internal Carotid Artery Pseudoaneurysm and Unilateral Vocal Cord Paralysis Secondary to Parapharyngeal Space Abscess	24
NORSE, FIRES, and a Polygenic Trickle of Autoimmunity	24
Social Health and Cognitive Change in Old Age: Role of Brain Reserve	24
Emerging Management Challenges Posed by Atrial Fibrillation Detected After Stroke	24
Sex Differences in Trends in Stroke Recurrence and Postrecurrence Mortality 2000–2020: Population‐Based Brain Attack Surveillance in Corpus Christi Project	24
High Levels of Perivascular Inflammation and Active Demyelinating Lesions at Time of Death Associated with Rapidly Progressive Multiple Sclerosis Disease Course: A Retrospective Postmortem Cohort Stud	23
Trametinib in Adults with Neurofibromatosis Type 1‐Related Symptomatic Plexiform Neurofibromas	23
“Don't Throw the Baby out with the Bathwater”	23
Temporal Pattern of Cortical Hypoxia in Multiple Sclerosis and Its Significance on Neuropsychological and Clinical Measures of Disability	23
Disease Characteristics and Treatments Associated with Outcome in Primary Angiitis of the Central Nervous System —A Multicenter Cohort Study in 163 P	23
	23
A Carotid Web with Atherosclerotic Plaque	23
AAV9‐DARS2 Gene Therapy Rescues Phenotype in Leukoencephalopathy with Brainstem and Spinal Cord Involvement and Lactate Elevation Patient Cells and Neuronal Dars2 D	23
Inflammation in Cerebral Amyloid Angiopathy‐Related Transient Focal Neurological Episodes	23
Network Localization of Pediatric Lesion‐Induced Dystonia	22
Role of the Exposome in Neurodegenerative Disease: Recent Insights and Future Directions	22
Reply to “Genetic Risk, Drug Regimens, and the Limits of Equitable Translation”	22
Disease Progression in Charcot–Marie–Tooth Disease Related to MPZ Mutations: A Longitudinal Study	22
Limbic Stimulation Drives Mania in STN‐DBS in Parkinson Disease: A Prospective Study	22
Systemic Metabolic Alteration Dependent on the Thyroid‐Liver Axis in Early PD	22
Polygenic Resistance to Blood Pressure Treatment and Stroke Risk: Insights from the All of Us Research Program	22
Salivary CGRP and Erenumab Treatment Response: Towards Precision Medicine in Migraine	22
Association of Apolipoprotein E ɛ4 Allele with Enlarged Perivascular Spaces	22
Activated Wake Systems in Narcolepsy Type 1	22
De Novo Missense Variants in SLC32A1 Cause a Developmental and Epileptic Encephalopathy Due to Imp	22
Insular Stimulation Produces Mental Clarity and Bliss	22
Diagnosing Epilepsy with Normal Interictal EEG Using Dynamic Network Models	22
Prediction of Cognitive Heterogeneity in Parkinson's Disease: A 4‐Year Longitudinal Study Using Clinical, Neuroimaging, Biological and Electrophysiological Biomarkers	22
Reply to “Reassessing the Impact of Endovascular Thrombectomy on Cerebral Edema and Functional Outcomes”	21
Reply to “Myelin Oligodendrocyte Glycoprotein Antibody‐Positive Patients Meeting the 2017 McDonald Criteria for Multiple Sclerosis: Challenges in Diagnosis and Treatment Decisions”	21
	21
Neutrophils Are Associated with Higher Risk of Incident Amyotrophic Lateral Sclerosis in a BMI‐ and Age‐Dependent Manner	21
Annals of Neurology: Volume 92, Number 3, September 2022	21
Fostering Academia‐Industry Partnerships to Facilitate Therapeutic Discoveries in Neurology: The Role of ANA as a Catalyst	21
MOG‐IgG‐Associated Bilateral Optic Neuritis in Temporal Relation to Monkeypox Vaccination	21
Decoding the Clinical Features that Associate with Progression, Causes, and Outcomes in Patients with Suspected Rapidly Progressive Dementia	21
	21
	21
MuSK‐Myasthenia Gravis and Cancer	21
Enhancement of Glutamate Uptake as Novel Antiseizure Approach: Preclinical Proof of Concept	21
Cinematic Rendering of Twig‐Like Middle Cerebral Artery	21
Issue Information	21
Intact HIV Proviruses Persist in the Brain Despite Viral Suppression with ART	20
Clinical and Molecular Genetic Characterization of Landau Kleffner Syndrome: An Observational Cohort and Experimental Study	20
Longitudinal Alterations of Cerebral Blood Flow in High‐Contact Sports	20
Myelin Oligodendrocyte Glycoprotein Antibody‐Positive Patients Meeting the 2017 McDonald Criteria for Multiple Sclerosis: Challenges in Diagnosis and Treatment Decisions	20
Phase 1 Evaluation of Elezanumab (Anti–Repulsive Guidance Molecule A Monoclonal Antibody) in Healthy and Multiple Sclerosis Participants	19
Networks Underlie Temporal Onset of Dysplasia‐Related Epilepsy: A MELD Study	19
Resilience to Endoplasmic Reticulum Stress Mitigates Membrane Hyperexcitability Underlying Late Disease Onset in a Murine Model of SCA6	19
Proteomic Indicators of Health Predict Alzheimer's Disease Biomarker Levels and Dementia Risk	19
Cluster Headache Genomewide Association Study and Meta‐Analysis Identifies Eight Loci and Implicates Smoking as Causal Risk Factor	19
Microglial and Astrocytic Responses in the Human Midcingulate Cortex in Huntington's Disease	19
Timing of Changes in Alzheimer's Disease Plasma Biomarkers as Assessed by Amyloid and Tau PET Clocks	19
Pathogenic Variants in RNU2‐2 , a Non‐coding Spliceosomal RNA , Cause a Distinctive Developmental and	19
Autosomal Recessive Cerebellar Ataxias: Translating Genes to Therapies	19
Blood‐Based Proteomics for Adult‐Onset Focal Dystonias	19
Levodopa Impairs the Energy Metabolism of the Basal Ganglia In Vivo	19
APOE Antibody Inhibits Aβ‐Associated Tau Seeding and Spreading in a Mouse Model	19
Divergent Causes and Convergent Mechanisms of SUDEP	19
Pragmatic Clinical Trials in Neurology	19
Presynaptic Dopaminergic Imaging Characterizes Patients with REM Sleep Behavior Disorder Due to Synucleinopathy	19
Spasticity Predicts Motor Recovery for Patients with Subacute Motor Complete Spinal Cord Injury	19
Neuroprotection of Low‐Frequency Repetitive Transcranial Magnetic Stimulation after Ischemic Stroke in Rats	19
Re‐Emergence of Poliovirus in the United States: Considerations and Implications	19
AI in Neurology: Everything, Everywhere, All at Once Part 3: Surveillance, Synthesis, Simulation, and Systems	19
Cognitive Effects of Deep Brain Stimulation in GBA‐Related Parkinson Disease	19
Life‐Limiting Peripheral Organ Dysfunction in Feline Sandhoff Disease Emerges after Effective CNS Gene Therapy	19
Annals of Neurology: Volume 90, Number 6, December 2021	19
Annals of Neurology: Volume 93, Number 4, April 2023	18
Obesity and Multiple Sclerosis Severity: A Mendelian Randomization Study	18
Disparate Dementia Risk Factors Are Associated with Cognitive Impairment and Rates of Decline in African Americans	18
Inhibition of Bone Morphogenetic Protein Signaling Prevents Tau Pathology in iPSC Derived Neurons and PS19 Mice	18
Annals of Neurology: Volume 95, Number 3, March 2024	18
Proteomics and the Risk of Incident Embolic and Thrombotic Stroke	18
Eligibility Rates among Racially and Ethnically Diverse US Participants in Phase 2 and Phase 3 Placebo‐Controlled, Double‐Blind, Randomized Trials of Lecanemab and Elenbecestat in Early Alz	18
Clinically Meaningful Magnetic Resonance Endpoints Sensitive to Preataxic Spinocerebellar Ataxia Types 1 and 3	18
Reply to “Type I IFN Signature in NOTCH1‐Related Leukoencephalopathy”	18
The Starry Cortex of Aβ‐Related Angiitis	18
Perimesencephalic Hemorrhage from A Superior Cerebellar Artery Dissection	18
Reply to “Letter to the Editor, Regarding ‘Intravenous Thrombolysis in Patients Taking Direct Oral Anticoagulation Treatment Before Stroke Onset: Results from the Safe Implementations of Treatments in	18
Longitudinal Retinal Changes in MOGAD	17
Cost‐Effectiveness of Endovascular Thrombectomy in Patients with Large Ischemic Stroke	17
Association of Mismatch Profiles and Clinical Outcome from Endovascular Therapy in Large Infarct: A Post‐Hoc Analysis of the ANGEL‐ASPECT Trial	17
	17
Early Treatment with Vigabatrin Does Not Decrease Focal Seizures or Improve Cognition in Tuberous Sclerosis Complex: The PREVeNT Trial	17
Mutations in CLCN6 as a Novel Genetic Cause of Neuronal Ceroid Lipofuscinosis in Patients and a Murine Model	17
Issue Information	17
Characterizing Frontal Lobe Seizure Semiology in Children	17
Divergent Associations of Slow‐Wave Sleep versus Rapid Eye Movement Sleep with Plasma Amyloid‐Beta	17
Amyloid‐Related Imaging Abnormalities in the DIAN‐TU‐001 Trial of Gantenerumab and Solanezumab: Lessons from a Trial in Dominantly Inherited Alzheimer Disease	17
Annals of Neurology: Volume 91, Number 2, February 2022	17
Letter on Spasticity Predicts Motor Recovery in Motor Complete Spinal Cord Injury	16
Mapping Molecular Pathways of Multiple Sclerosis: A Gene Prioritization and Network Analysis of White Matter Pathology Transcriptomics	16
Reply to Suvorexant for Preventing Alzheimer's Disease	16
Independent Confirmation	16